Saltar al contenido principal
Saltar al pie de página
What We Do
What We Do
What We Do
#Reputation
#Legislative
Data Lake
#people
Contact center
AI Assistants
Sport
Our Contribution
View All
Competitive intelligence for B2G public procurement
The Communications Director's Problem: How to demonstrate that communication adds value to the business
Areas
Areas
Areas
Corporate Communication
Reputation and brand
Managers and leadership
Public affairs
Marketing and sponsorship
Audiences and territory
Sport and talent
Media and reporting
Public institutions
Our Contribution
View All
Competitive intelligence for B2G public procurement
The Communications Director's Problem: How to demonstrate that communication adds value to the business
Services
Services
Services
Consulting
Reports
Business Intelligence
Our Contribution
View All
Competitive intelligence for B2G public procurement
The Communications Director's Problem: How to demonstrate that communication adds value to the business
Who We Are
Publications
Publications
Reports
Competitive intelligence for B2G public procurement
The legitimacy of the innovative pharmaceutical industry 2026 Q1
View all
News
The Communications Director's Problem: How to demonstrate that communication adds value to the business
Daily Impact: Enigmia's tool to measure a brand's daily reputational impact
View all
Buscar
EN
EN
ES
PT
FR
DE
IT
Contact
Este navegador no soporta la etiqueta de vídeo.
Buscar
SEARCH
What We Do
Areas
Services
Who We Are
Publications
Back to
What We Do
#Reputation
#Legislative
Data Lake
#people
Contact center
AI Assistants
Sport
Back to
Areas
Corporate Communication
Reputation and brand
Managers and leadership
Public affairs
Marketing and sponsorship
Audiences and territory
Sport and talent
Media and reporting
Public institutions
Back to
Services
Consulting
Reports
Business Intelligence
Back to
Our Contribution
Reports
News
Contact
Reports
Buscar
Search
The legitimacy of the innovative pharmaceutical industry 2026 Q1
The innovative pharmaceutical industry occupies a unique position in the public sphere. Its activity is linked to science, health, investment, research, medical innovation, and improving patients' lives. But it also operates in a particularly demanding environment, where regulation, drug pricing, patents, and other factors play a significant role.
Read
now
The architecture of talent: how to analyze the reputation and value of public figures with data
How to measure the reputation, popularity and personality of athletes, entrepreneurs, politicians or influencers through data analysis. Discover the approach of The Architecture of Talent and Enigmia Sport.
Read
now
Observatory of Spain's Management Value in the World 2025: global leadership turned into data
The Observatory of the Managerial Value of Spain in the World 2025, promoted by the Conexión España Foundation and developed with Enigmia, demonstrates with empirical evidence that Spanish managerial talent has consolidated itself as a true strategic asset of the country. A rigorous analysis of its impact, reputation and international projection.
Read
now
Princess Eleanor's institutional projection (2023-2025)
Analysis of the media and institutional evolution of Princess Eleanor between 2023 and 2025: trends, implications for the public agenda and strategic keys for organizations and the media.
Read
now
Impact of the Basketball King’s Cup
Explore the complete analysis of the economic, tourism, technological and sponsorship impact of the Basketball King's Cup from 2020 to today. A key report for public entities, sponsors and sports organizations looking to make data-driven decisions.
Read
now
Ten years of Felipe VI's reign, impact and usefulness of the crown in Spain
This report analyzes in depth the evolution of the reign of His Majesty King Felipe VI during his first 10 years, assessing his impact on Spanish society, his contribution to territorial cohesion and his international positioning. In a context of profound social, economic and political changes, the Crown has faced the challenge of...
Read
now
GET ALL THE NEWS
Sign up here to stay up to date with all the latest news.
Our partnership
We've detected you might be speaking a different language. Do you want to change to:
Spanish
Spanish
English
Portuguese
French
German
Italian
Change Language
Close and do not switch language
We've detected you might be speaking a different language. Do you want to change to:
Spanish
Spanish
English
Portuguese
French
German
Italian
Change Language